Search

Julie E. Bauman, MD, MPH
Julie E. Bauman, MD, MPH is director of the GW Cancer Center as well as associate dean of cancer and professor of medicine at the GW School of Medicine & Health Sciences. Bauman completed a dual MD/MPH degree at Tufts University School of Medicine, internal medicine residency at the University…
A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients with Advanced Malignancies
This is an open-label, non-randomized, multicenter, dose-escalation and expansion study in patients with selected solid tumors.
A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Elizabeth Bluhm, MD, MPH, FACP
Elizabeth Bluhm, MD, MPH, is an internist at the GW Medical Faculty Associates and an assistant professor of medicine at the George Washington University School of Medicine and Health Sciences. She graduated from Williams College and the Mount Sinai School of Medicine. She was a resident in…
Michael Czarnecki, DO
Robert Jablonover, MD
Dr. Robert Jablonover is an internal medicine physician with The GW Medical Faculty Associates and an assistant professor at The George Washington University School of Medicine & Health Sciences. Following his residency in Internal Medicine in 1992 at the University of Maryland, he worked at…
Mia Marcus, MD
Chavon Onumah, MD, MPH, FACP
Chavon Onumah, MD, MPH, MEd, FACP is an Associate Professor of Medicine in the General Internal Medicine Division at the George Washington University School of Medicine and Health Sciences.
A Phase 1/2 Randomized, Observer-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Varicella Zoster Virus in Healthy Individuals
The purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune system's reaction) of the study vaccine called Varicella Zoster Virus modRNA (VZV modRNA). We are seeking for healthy participants who are between 50…
5 Myths About the Flu Vaccine
The flu shot is the first line of defense. Help protect yourself and your family against the influenza virus. When it’s flu season, take the necessary steps to stay healthy. That means separating fact from fiction.